MetaStat, Inc. (MTST)

OTCMKTS · Delayed Price · Currency is USD
0.0006
-0.0001 (-14.29%)
At close: Dec 29, 2025
500.00%
Market Cap3.53K
Revenue (ttm)23.30K
Net Income (ttm)-3.31M
Shares Out5.88M
EPS (ttm)-0.61
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,598
Average Volume25,881
Open0.0006
Previous Close0.0007
Day's Range0.0006 - 0.0006
52-Week Range0.0001 - 0.0844
Beta307.01
RSI47.71
Earnings Daten/a

About MetaStat

MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid bl... [Read more]

Industry Biotechnology
Sector Healthcare
Employees 6
Stock Exchange OTCMKTS
Ticker Symbol MTST
Full Company Profile

Financial Performance

Financial Statements